Epidemiology and infection control of Methicillin-resistant Staphylococcus aureus in a German tertiary neonatal intensive and intermediate care unit: A retrospective study (2013–2020)

Abstract

In preterm and term infants who require intermediate or intensive care Methicillin-resistant Staphylococcus aureus (MRSA) infection can lead to significant morbidity. In this study MRSA colonization and infection were assessed in a mixed tertiary neonatal intensive and intermediate care unit in Germany over an 8-year period (2013–2020). We investigated patient-related factors, associated with nosocomial MRSA acquisition, and we discuss our infection control concept for MRSA. Of 3488 patients treated during the study period, 24 were MRSA positive patients, corresponding to 26 patient hospital stays. The incidence was 0.7 MRSA patients per 100 patients. The incidence density was 0.4 MRSA patient hospital stays per 1000 patient days. Twelve patients (50%) acquired MRSA in the hospital. One patient developed a hospital acquired MRSA bloodstream infection 9 days after birth (i.e., 0.03% of all patients on the ward during the study period). A total of 122 patients had to be screened to detect one MRSA positive patient. In a logistic regression model, the use of 3rd generation intravenous cephalosporin (cefotaxim) was associated with nosocomial MRSA acquisition compared with matched control patients who did not acquire MRSA. In sum, the burden of MRSA colonization and infection in the ward was low during the study period. A comprehensive infection control concept that included microbiologic colonization screening, prospective infection surveillance together with isolation and emphasis on basic hygiene measures is essential to handle MRSA in this specialized setting.

Update Perioperative Antibiotikaprophylaxe in der Neonatologie

“…Nur Patienten, die mit MRSA besiedelt sind, erhalten eine PAP; die um Vancomycin oder Teicoplanin erweitert wird ‡. Ob bei einzelnen mit S. aureus besiedelten Patienten vor einer Operation eine Dekolonisierung versucht wird, sollte individuell entschieden werden [56,57,58]. Bei Patienten, die mit MRGN besiedelt sind, sollte die PAP vor geplanten Operationen wenn möglich in einem ABS-Konsil individuell festgelegt werden [15,39,59,60].…”

Update Perioperative Antibiotikaprophylaxe in der Neonatologie

“…Nur Patienten, die mit MRSA besiedelt sind, erhalten eine PAP; die um Vancomycin oder Teicoplanin erweitert wird †. Ob bei einzelnen mit S. aureus besiedelten Patienten vor einer Operation eine Dekolonisierung versucht wird, sollte individuell entschieden werden[55][56][57]. Bei Patienten, die mit MRGN besiedelt sind, sollte die PAP vor geplanten Operationen wenn möglich in einem ABS-Konsil individuell festgelegt werden[14,38,58,59].…”